Cargando…

Effect of patient thickness on acute gastrointestinal toxicities following radiotherapy for prostate cancer

BACKGROUND: There is conflicting literature regarding the effect of patient size on radiotherapy toxicities. This study aimed to determine whether there is any association between patient thickness and severity and incidence of acute GI toxicities of prostate cancer patients receiving VMAT radiother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pisani, Robert, Bezzina, Paul, Couto, Jose Guilherme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281905/ https://www.ncbi.nlm.nih.gov/pubmed/34277088 http://dx.doi.org/10.5603/RPOR.a2021.0053

Ejemplares similares

Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer
por: Peach, Matthew Sean, et al.
Publicado: (2015)

Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
por: D’Avino, Vittoria, et al.
Publicado: (2015)

Nomogram to predict rectal toxicity following prostate cancer radiotherapy
por: Delobel, Jean-Bernard, et al.
Publicado: (2017)

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer
por: Kerns, Sarah L., et al.
Publicado: (2016)

Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
por: Gill, Suki, et al.
Publicado: (2011)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
por: Cella, Laura, et al.
Publicado: (2013)

RADIOTHERAPY OF PROSTATE CANCER: PRIMARY RADIOTHERAPY AND RADIOTHERAPY IN DISEASE RELAPSE
por: Antunac, Katarina
Publicado: (2019)

Dosimetric correlation of acute and late toxicities in high-risk prostate cancer patients treated with three-dimensional conformal radiotherapy followed by intensity modulated radiotherapy boost
por: Kapoor, Rakesh, et al.
Publicado: (2016)

Helical tomotherapy experience in breast cancer adjuvant radiotherapy and acute toxicity results
por: İnan, Gonca Altınışık, et al.
Publicado: (2022)

Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer
por: Ferreira, M.R., et al.
Publicado: (2019)

Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity
por: Rudat, Volker, et al.
Publicado: (2015)

Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients
por: Peng, Xingsi, et al.
Publicado: (2019)

Hematologic Toxicity of Conformal Radiotherapy and Intensity Modulated Radiotherapy in Prostate and Bladder Cancer Patients
por: Miszczyk, Marcin, et al.
Publicado: (2018)

Radiotherapy-induced toxicity in prostate cancer patients with hip prostheses
por: Fischer, Andrea M., et al.
Publicado: (2022)

Impact of treatment planning and delivery factors on gastrointestinal toxicity: an analysis of data from the RADAR prostate radiotherapy trial
por: Yahya, Noorazrul, et al.
Publicado: (2014)

A prospective comparison of acute intestinal toxicity following whole pelvic versus small field intensity-modulated radiotherapy for prostate cancer
por: Kim, Yeon Joo, et al.
Publicado: (2016)

Impact of reduced margin pelvic radiotherapy on gastrointestinal toxicity and outcome in gynecological cancer
por: Lee, Jie, et al.
Publicado: (2023)

NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer
por: Berlin, Alejandro, et al.
Publicado: (2014)

Biochemical failure and toxicity in treatment with brachytherapy and external beam radiotherapy compared with radical prostatectomy in localized prostate cancer
por: Galdos-Bejar, Marcelo, et al.
Publicado: (2022)

Comparison of acute gastrointestinal toxicities between 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy including prophylactic regions in chemoradiotherapy with S-1 for pancreatic cancer—importance of dose volume histogram parameters in the stomach as the predictive factors-
por: Umezawa, Rei, et al.
Publicado: (2022)

Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer
por: Hunter, Grant K., et al.
Publicado: (2012)

A Comparison of Gastrointestinal Toxicities between Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy for Pancreatic Cancer
por: Lee, Kyong Joo, et al.
Publicado: (2016)

Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trial
por: Kim, Julian O., et al.
Publicado: (2021)

Toxicity of dose-escalated radiotherapy up to 84 Gy for prostate cancer
por: Rosenbrock, Johannes, et al.
Publicado: (2023)

Complications following surgery with or without radiotherapy or radiotherapy alone for prostate cancer
por: Wallis, C J D, et al.
Publicado: (2015)

Comparative effectiveness of radical prostatectomy and curative radiotherapy in localized prostate cancer: long-term follow-up
por: Tamada, Satoshi, et al.
Publicado: (2017)

Hypofractionated radiotherapy in postmastectomy locally advanced breast cancer: an interim report on acute toxicities and dosimetry
por: Jamora, Kurl, et al.
Publicado: (2022)

AMPK activation by AICAR sensitizes prostate cancer cells to radiotherapy
por: Rae, Colin, et al.
Publicado: (2019)

Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis
por: Li, Xuanzhe, et al.
Publicado: (2023)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in pancreatic adenocarcinoma
por: Liu, Xian, et al.
Publicado: (2016)

Impact of diabetes on gastrointestinal and urinary toxicity after radiotherapy for gynecologic malignancy
por: Özkan, Emine Elif, et al.
Publicado: (2019)

Gastrointestinal toxic effects in patients with cancer receiving platinum-based therapy
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2020)

Efficacy and Toxicity of Whole Pelvic Radiotherapy Versus Prostate-Only Radiotherapy in Localized Prostate Cancer: A Systematic Review and Meta-Analysis
por: Wang, Shilin, et al.
Publicado: (2022)

Modeling of Acute Rectal Toxicity to Compare Two Patient Positioning Methods for Prostate Cancer Radiotherapy: Can Toxicity Modeling be Used for Quality Assurance?
por: Liu, X, et al.
Publicado: (2018)

Minimal Rectal Toxicity in the Setting of Comorbid Crohn’s Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer
por: Singh, Raj, et al.
Publicado: (2017)

Dose-volume analysis of planned versus accumulated dose as a predictor for late gastrointestinal toxicity in men receiving radiotherapy for high-risk prostate cancer
por: Ong, Ashley L.K, et al.
Publicado: (2022)

Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: a single centre analysis of toxicity and clinical outcome
por: Riva, Giulia, et al.
Publicado: (2017)

Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab
por: Cao, Lu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_omm1bf6scrgp2j5idcjeofsc47